Alaunos Therapeutics | ZIOP - Gross Profit On Sales


Alaunos Therapeutics reported $-1.13M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Amgen USD 6.48B 307M Sep/2025
AstraZeneca USD 12.39B 5M Dec/2025
Baxter International USD 577M 373M Dec/2025
Biogen USD 1.65B 34.6M Dec/2025
Bioline Rx USD 343K 111K Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Celltrion KRW 626.11B 81.75B Sep/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Cspc Pharmaceutical CNY 4.34B 333.68M Sep/2025
Curis USD -7.72M 140K Jun/2024
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Incyte USD 1.39B 118.68M Dec/2025
Intrexon USD -297K 167K Jun/2024
Ionis Pharmaceuticals USD 195M 40M Dec/2025
J&J USD 16.6B 118M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
Knight Therapeutics CAD 55.81M 10.98M Sep/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Merck USD 13.42B 431M Sep/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Novartis USD 10.82B 695M Sep/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Pharma Mar EUR 86.7M 53.34M Dec/2025
PTC Therapeutics USD 148.38M 39.31M Dec/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sartorius EUR 393.2M 23M Sep/2025
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
TG Therapeutics USD 154.43M 20.81M Dec/2025
Tilray USD 67.63M 15.62M Mar/2025
Verastem USD 545K 543K Dec/2021
Zz Pientze Pharmaceu CNY 296.13M 1.1B Jun/2025